Left Brain Wealth Management LLC Sells 136 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Left Brain Wealth Management LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 4,083 shares of the healthcare conglomerate’s stock after selling 136 shares during the period. Left Brain Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,065,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $40,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on UNH shares. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH stock opened at $480.79 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average price of $511.85 and a two-hundred day moving average price of $551.01. The firm has a market cap of $439.78 billion, a P/E ratio of 31.02, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.